技术辅助远程认知行为疗法干预(Tech-CBT)对比常规照护以减少轻度认知障碍和痴呆患者焦虑的单盲平行组随机试验:随机试验研究方案
本研究为混合II型单盲平行组随机试验方案,比较Tech-CBT干预(n=35)与常规照护(n=35)对轻度认知障碍和痴呆患者焦虑的疗效、成本效果、可用性和可接受性。干预包括每周六次由心理学研究生通过远程医疗视频会议提供的会话、语音助手应用家庭练习及数字平台My Anxiety Care。主要结局为痴呆焦虑评定量表变化。
要点
- Tech-CBT为技术辅助远程认知行为疗法,含每周六次远程会话、语音助手应用和数字平台。
- 主要结局为痴呆焦虑评定量表(Rating Anxiety in Dementia scale)变化。
- 试验将进行过程评价、定性访谈和成本效用分析。
核心结论
- 这是首个评估新型技术辅助CBT干预以减少轻度认知障碍和痴呆患者焦虑的试验。
研究设计与样本
- 混合II型单盲平行组随机试验,Tech-CBT干预组n=35,常规照护组n=35。
- 干预包括每周六次由心理学研究生通过远程医疗视频会议提供的会话,结合语音助手应用进行家庭练习,并使用专用数字平台My Anxiety Care。
- 内置混合方法过程评价和经济评价,以指导未来推广和实施。
主要发现
- 主要结局为痴呆焦虑评定量表测量的焦虑变化。
- 次要结局包括生活质量和抑郁变化及照护者结局。
- 过程评价将遵循评价框架,对参与者(n=10)和照护者(n=10)进行定性访谈以评估可接受性和可行性及参与和依从性的影响因素。
- 还将对治疗师(n=18)和更广泛利益相关者(n=18)进行访谈,探讨未来实施和可扩展性的背景因素及障碍/促进因素。
- 将进行成本效用分析以确定Tech-CBT相比常规照护的成本效果。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Anxiety is commonly experienced by people living with mild cognitive impairment (MCI) and dementia. Whilst there is strong evidence for late-life anxiety treatment using cognitive behavioural therapy (CBT) and delivery via telehealth, there is little evidence for the remote delivery of psychological treatment for anxiety in people living with MCI and dementia. This paper reports the protocol for the Tech-CBT study which aims to investigate the efficacy, cost-effectiveness, usability and acceptability of a technology-assisted and remotely delivered CBT intervention to enhance delivery of anxiety treatment for people living with MCI and dementia of any aetiology. METHODS: A hybrid II single-blind, parallel-group randomised trial of a Tech-CBT intervention (n = 35) versus usual care (n = 35), with in-built mixed methods process and economic evaluations to inform future scale-up and implementation into clinical practice. The intervention (i) consists of six weekly sessions delivered by postgraduate psychology trainees via telehealth video-conferencing, (ii) incorporates voice assistant app technology for home-based practice, and (iii) utilises a purpose-built digital platform, My Anxiety Care. The primary outcome is change in anxiety as measured by the Rating Anxiety in Dementia scale. Secondary outcomes include change in quality of life and depression, and outcomes for carers. The process evaluation will be guided by evaluation frameworks. Qualitative interviews will be conducted with a purposive sample of participants (n = 10) and carers (n = 10), to evaluate acceptability and feasibility, as well as factors influencing participation and adherence. Interviews will also be conducted with therapists (n = 18) and wider stakeholders (n = 18), to explore contextual factors and barriers/facilitators to future implementation and scalability. A cost-utility analysis will be undertaken to determine the cost-effectiveness of Tech-CBT compared to usual care. DISCUSSION: This is the first trial to evaluate a novel technology-assisted CBT intervention to reduce anxiety in people living with MCI and dementia. Other potential benefits include improved quality of life for people with cognitive impairment and their care partners, improved access to psychological treatment regardless of geographical location, and upskilling of the psychological workforce in anxiety treatment for people living with MCI and dementia. TRIAL REGISTRATION: This trial has been prospectively registered with ClinicalTrials.gov: NCT05528302 [September 2, 2022].
引用
- Dissanayaka N, Brooks D, Worthy P, et al. A single-blind, parallel-group randomised trial of a Technology-assisted and remotely delivered Cognitive Behavioural Therapy intervention (Tech-CBT) versus usual care to reduce anxiety in people with mild cognitive impairment and dementia: study protocol for a randomised trial. Trials. 2023. PMID: 37340492. doi:10.1186/s13063-023-07381-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。